Teva Pharmaceuticals USA, Inc. recalls Methylphenidate Hydrochloride Extended-Release Capsules (LA), 20 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA

Recalled August 14, 2013 · FDA recall D-847-2013 · Teva Pharmaceuticals USA

Hazard

Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing. · FDA Class II

Units

16,293 bottles

Sold at

Nationwide

Description

Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.

Product

Methylphenidate Hydrochloride Extended-Release Capsules (LA), 20 mg, 100 count bottle, Rx only, TEVA PHARMACEUTICALS USA, NDC 0093-5346-01

Manufacturer(s)

Teva Pharmaceuticals USA, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →